Women's Health

PHILADELPHIA — Nearly 60% of women with systemic sclerosis reported that their sexuality was negatively impacted by their disease, according to data presented at ACR Convergence 2022.

WASHINGTON — In a Healio video exclusive, Leen Al-Sayyed, MD, gastroenterology and transplant hepatology fellow at St. Louis University, reported women with nonalcoholic steatohepatitis-cirrhosis had an increased prevalence for polypharmacy.

ANAHEIM, Calif. — Interactions between endocrine-disrupting chemicals and race may affect the elevated incidence of uterine fibroids among Black women, according to results presented here.

Research published in The Journal of Clinical Endocrinology & Metabolism highlighted the need for better evidence on long-term health consequences of gestational diabetes.

ANAHEIM, Calif. — Instagram users are engaging content about polycystic ovarian syndrome from accounts dedicated to the topic, and patients can be encouraged to find support there, according to findings presented here.

ANAHEIM, Calif. — Women with polycystic ovary syndrome may be more likely to have cognitive decline and reductions in white brain matter integrity than those without PCOS, according to a presenter.

Women diagnosed with type 1 diabetes before age 30 years or type 2 diabetes at age 30 to 39 years are more likely to reach menopause earlier than women without diabetes, according to study results.

Women who did not receive menopausal hormone therapy had greater odds of developing adhesive capsulitis compared with those on HT, according to preliminary study results presented at the North American Menopause Society annual meeting.

The CHEST Annual Meeting will be held Oct. 16 to 19 in Nashville, Tennessee, with a broad focus on bringing the pulmonology community back together in person.

Regional differences in hormonal and metabolic profiles in polycystic ovary syndrome exist between women in Alabama, who are more likely to have hirsutism, and those California, who are more likely to have hyperandrogenemia.